Gain Therapeutics, Inc. 8-K

What Happened
Gain Therapeutics, Inc. (GANX) filed a Current Report on Form 8-K on February 3, 2026 under Item 7.01 (Regulation FD Disclosure) to announce that it posted slides describing its business on its website. The slides were included in the filing as Exhibit 99.1. The 8-K also lists exhibit attachments (including the Inline XBRL cover page, Exhibit 104).

Key Details

• Filing date: February 3, 2026 (Form 8-K).
• Item reported: 7.01 — Regulation FD Disclosure; slides attached as Exhibit 99.1.
• Exhibit listing: Exhibit 99.1 (Investor Presentation) and Exhibit 104 (Cover Page Interactive Data File).
• The filing does not report earnings, financial results, executive changes, mergers, or other material corporate events.

Why It Matters
This filing publicly shares Gain Therapeutics’ investor presentation under Regulation FD, meaning the company disclosed these slides broadly rather than selectively. For investors, this is informational material about the company’s business and should not be interpreted as a quarterly earnings release or a change in management. Review the posted presentation (available on the company website and in the SEC filing) for details; monitor future SEC filings for material financial results or other significant events.